Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Discover the patented CN101362728A method for Valsartan synthesis featuring improved purity, safer azide handling, and cost-effective manufacturing processes for global supply chains.
Patent CN110835639A reveals a dual-enzyme DKR process for high-purity (S)-tetrahydroisoquinoline derivatives, offering superior ee values and scalable manufacturing for pharmaceutical intermediates.
Patent CN109182410B details a high-yield biocatalytic route for chiral piperidine intermediates, offering significant cost reduction in API manufacturing and superior supply chain reliability.
Patent CN118638174A reveals a plant-based UDCA synthesis route. Achieve 99.91% purity with reduced viral risk and scalable enzymatic steps for reliable supply.
Patent CN109852593B details a high-activity CmCR mutant for R-3HB production, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN109970753B details organocatalytic synthesis of xanthone-oxindole hybrids. Offers high stereoselectivity and anti-tumor potential for drug discovery.
Patent CN113174377A reveals stable carbonyl reductase mutants for high-yield diltiazem intermediate synthesis, offering cost-effective biocatalysis solutions.
Patent CN119119158A reveals a novel plant-derived route for ursodeoxycholic acid. Achieve high purity and cost reduction in API manufacturing with scalable bio-hybrid synthesis.
Novel patent CN117756746A offers high-yield cyclic sulfonamide synthesis. Mild conditions and NHC-borane catalyst ensure cost-effective pharmaceutical intermediate manufacturing.
Patent CN103012311A details a novel etherification method using distilled isobutane bromide to eliminate n-propoxy impurities, ensuring superior API quality and supply reliability.
Patent CN102199146A details a high-yield catalytic transfer hydrogenation for Imatinib intermediates, offering superior purity and supply chain reliability for global pharmaceutical manufacturers.
Novel reduction method for Riociguat intermediate ensures high purity and safety. Offers significant supply chain advantages for pharmaceutical manufacturing partners.
Patent CN109970725A reveals a mild debenzylation method for posaconazole. This process offers significant supply chain stability and cost reduction advantages.
Patent CN101220008B reveals a novel synthesis for ABT-263 intermediates, offering significant yield improvements and cost reduction in pharmaceutical manufacturing through catalytic oxidation.
Patent CN105330715B enables high-purity TUDCA synthesis with improved supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing.
Novel solid-phase synthesis method for Apraglutide improves yield and purity. Reduces hydrophobic aggregation issues for reliable pharmaceutical intermediate supply.
Patent CN110804062B details a high-yield synthesis of chiral lactone for biotin. Discover cost-effective manufacturing and scalable supply chain solutions.
Patent CN114933619A discloses potent thioglycoside analogs with nanomolar IC50. Streamlined Pd-catalyzed synthesis offers cost-effective pharma intermediate supply.
Patent CN105130958B reveals a safer Topiroxostat route. Discover cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing.
Patent CN104628584A reveals a mild synthesis route for dapoxetine. Achieve 99.9% purity with reduced toxicity and significant cost reduction in API manufacturing.